These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 9035136

  • 1. A new class of viral inhibitor.
    Nat Biotechnol; 1997 Feb; 15(2):135. PubMed ID: 9035136
    [No Abstract] [Full Text] [Related]

  • 2. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X, Gaubin M, Briant L, Srikantan V, Murali R, Saragovi U, Weiner D, Devaux C, Autiero M, Piatier-Tonneau D, Greene MI.
    Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
    [Abstract] [Full Text] [Related]

  • 3. Peptide T revisited: conformational mimicry of epitopes of anti-HIV proteins.
    Picone D, Rivieccio A, Crescenzi O, Caliendo G, Santagada V, Perissutti E, Spisani S, Traniello S, Temussi PA.
    J Pept Sci; 2001 Apr; 7(4):197-207. PubMed ID: 11354463
    [Abstract] [Full Text] [Related]

  • 4. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y, Ochiai C, Yoshimura K, Tanaka T, Ohashi N, Narumi T, Nomura W, Harada S, Matsushita S, Tamamura H.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):354-8. PubMed ID: 19926478
    [Abstract] [Full Text] [Related]

  • 5. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
    Biorn AC, Cocklin S, Madani N, Si Z, Ivanovic T, Samanen J, Van Ryk DI, Pantophlet R, Burton DR, Freire E, Sodroski J, Chaiken IM.
    Biochemistry; 2004 Feb 24; 43(7):1928-38. PubMed ID: 14967033
    [Abstract] [Full Text] [Related]

  • 6. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT, Meyer B.
    Angew Chem Int Ed Engl; 2004 May 24; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract] [Full Text] [Related]

  • 7. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
    Caporuscio F, Tafi A, González E, Manetti F, Esté JA, Botta M.
    Bioorg Med Chem Lett; 2009 Nov 01; 19(21):6087-91. PubMed ID: 19783140
    [Abstract] [Full Text] [Related]

  • 8. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
    Tintori C, Selvaraj M, Badia R, Clotet B, Esté JA, Botta M.
    ChemMedChem; 2013 Mar 01; 8(3):475-83. PubMed ID: 23404750
    [Abstract] [Full Text] [Related]

  • 9. Molecular dynamics study of the proposed beta-hairpin form of the switch domain from HIV1 gp120 alone and complexed with an inhibitor of CD4 binding.
    Graf von Stosch A, von der Lieth CW, Reed J.
    Proteins; 1999 Feb 01; 34(2):197-205. PubMed ID: 10022355
    [Abstract] [Full Text] [Related]

  • 10. Rational conversion of noncontinuous active region in proteins into a small orally bioavailable macrocyclic drug-like molecule: the HIV-1 CD4:gp120 paradigm.
    Hurevich M, Swed A, Joubran S, Cohen S, Freeman NS, Britan-Rosich E, Briant-Longuet L, Bardy M, Devaux C, Kotler M, Hoffman A, Gilon C.
    Bioorg Med Chem; 2010 Aug 01; 18(15):5754-61. PubMed ID: 20619663
    [Abstract] [Full Text] [Related]

  • 11. Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments.
    Cheng K, El-Boubbou K, Landry CC.
    ACS Appl Mater Interfaces; 2012 Jan 01; 4(1):235-43. PubMed ID: 22117536
    [Abstract] [Full Text] [Related]

  • 12. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H, Song H, Heredia A, Le N, Redfield R, Lewis GK, Wang LX.
    Bioconjug Chem; 2004 Jan 01; 15(4):783-9. PubMed ID: 15264865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.